Condition
OSDI
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Completed4
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06656260Not Yet Recruiting
Validation of Ocular Pain Questionnaire: Single-center, Prospective Observational Study
NCT06505174Completed
Effect of Treatment With Systane Ultra in Symptomatology and Visual Task Efficiency in Digital Device Users
NCT06499753Completed
Differences in Dry Eye Symptoms Related to Geographic Location in Spain and Impact of Artificial Tears Use
NCT04949295Completed
Evaluation of Ocular Surface in Hemodialysis Patients by Ocular Surface Analyzer
NCT00567983Phase 4Completed
Topical Cyclosporine and Disease Progression
Showing all 5 trials